The 95 references in paper I. Kozlov A., И. Козлов А. (2013) “Агонист α2-адренорецепторов дексмедетомидин в практике современной седации // The α2-Adrenoceptor Agonist Dexmedetomidine in Current Sedation Practice” / spz:neicon:reanimatology:149

1
Белышев С.Ю., Левит А.Л.Седация в интенсивной терапии. Обзор современного состояния проблемы. Общая реаниматология.2012; 8 (3): 56—62.
(check this in PDF content)
2
Заболотских И.Б., Песняк Е.В.Седация в интенсивной терапии. Петрозаводск: ИнтелТек; 2007.
(check this in PDF content)
3
Овечкин А.М. Анальгезия и седация в интенсивной терапии. Вестн. интенс. терапии.2009; 1: 17—25.
(check this in PDF content)
4
Федарау М., Комполо Ф., Пападокос П.Психомоторное возбуждение и делирий у больных в критических состояниях и роль седации. Общая реаниматология.2012; 8 (6): 62—74.
(check this in PDF content)
5
Barr J., Fraser G.L., Puntillo K., Ely E.W., GélinasC., Dasta J.F., Davidson J.E., Devlin J.W., Kress J.P., Joffe A.M., Coursin D.B., Herr D.L., Tung A., Robinson B.R., Fontaine D.K., Ramsay M.A., Riker R.R., Sessler C.N., Pun B., Skrobik Y., Jaeschke R.Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit. Care Med.2013; 41 (1): 263—306.
(check this in PDF content)
6
Bloor B.C., Flacke W.E.Reduction in halothane anesthetic requirement by clonidine, an alpha-adrenergic agonist. Anesth. Analg.1982; 61 (9): 741—745.
(check this in PDF content)
7
Kaukinen S.Effects of antihypertensive medication on the cardiovascular response to ketamine in rats. Acta Anaesthesiol. Scand.1978; 22 (4): 437—446.
(check this in PDF content)
8
Kaukinen S., PyykköK. The potentiation of halothane anaesthesia by clonidine. Acta Anaesthesiol. Scand.1979; 23 (1): 107—111.
(check this in PDF content)
9
Kaukinen S., Ylitalo P.The effects of antihypertensive medication on the control of the cardiovascular system during halothane anaesthesia in rats. Acta Anaesthesiol. Scand.1978; 22 (1): 64—75.
(check this in PDF content)
10
Segal I.S., Vickery R.G., Walton J.K., Doze V.A., Maze M. Dexmedetomidine diminishes halothane anesthetic requirements in rats through a postsynaptic alpha 2 adrenergic receptor. Anesthesiology. 1988; 69 (6): 818—823.
(check this in PDF content)
11
Boussofara M., Mtaallah M.H., Nefaa M.N., Kaddour C.Clonidine and anesthesia. Tunis Med.2004; 82 (3): 249—257.
(check this in PDF content)
12
Maze M., Segal I.S., Bloor B.C.Clonidine and other alpha2-adrenergic agonists: strategies for the rational use of these novel anesthetic agents. J. Clin.Anesth. 1988; 1 (2): 146—157.
(check this in PDF content)
13
Mizobe T., Maze M.Alpha2-adrenoceptor agonists and anesthesia. Int. Anesthesiol. Clin.1995; 33 (1): 81—102.
(check this in PDF content)
14
Martin J., Parsh A., Franck M., Wernecke K.D., Fisher M., Spies C. Practice of sedetion and analgesia in German intensive care units: results of a national survey. Crit. Care.2005; 9 (2): R117—R123.
(check this in PDF content)
15
O’Connor M., Bucknall T., Manias E.Sedation management in Australia and New Zealand intensive care units: doctors’ and nurses’ practices and opinions. Am. J. Crit. Care. 2010; 19 (3): 285—295.
(check this in PDF content)
16
Wunsch H., Kahn J.M., Kramer A.A., Rubenfeld G.D.Use of intravenous infusion sedation among mechanically ventilated patients in the United States. Crit. Care Med.2009; 37 (12): 3031—3039.
(check this in PDF content)
17
Wunsch H., Kahn J.M., Kramer A.A., Wagener G., Li G., Sladen R.N., Rubenfeld G.D.Dexmedetomidine in the care of critically ill patients from 2001 to 2007: an observational cohort study. Anesthesiology.2010; 113 (2): 386—394.
(check this in PDF content)
18
Jakob S.M., Ruokonen E., Grounds R.M., Sarapohja T., Garratt C., Pocock S.J., Bratty J.R., Takala J.Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA.2012; 307 (11): 1151—1160.
(check this in PDF content)
19
Ahlquist R.P.A study of the adrenotropic receptors. Am. J. Physiol.1948; 153 (3): 586—600.
(check this in PDF content)
20
Kamibayashi T., Maze M.Clinical uses of alpha2-adrenergic agonists. Anesthesiology.2000; 93 (5): 1345—1349.
(check this in PDF content)
21
Дыгало Н.Н. Рецепторы гормонов, нейротрансмиттеров и тканевых факторов. Новосибирск: изд-во НГУ; 2001.
(check this in PDF content)
22
Шишкина Г.Т., Дыгало Н.Н. Подтип-специфические клинически важные эффекты альфа2-адренорецепторов. Успехи физиол. наук. 2002; 33 (2): 30—40.
(check this in PDF content)
23
Virtanen R., Savola J.M., Saano V., Nyman L.Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2adrenoceptor agonist. Eur. J. Pharmacol.1988; 150 (1—2): 9—14.
(check this in PDF content)
24
Brown E.N., Lydic R., Schiff N.D.General anesthesia, sleep, and coma. N. Engl. J. Med.2010; 363 (27): 2638—2650.
(check this in PDF content)
25
Nelson L.E., Lu J., Guo T., Saper C.B., Franks N.P., Maze M.The alpha2adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology. 2003; 98 (2): 428—436.
(check this in PDF content)
26
Huupponen E., Maksimow A., Lapinlampi P., SärkeläM., Saastamoinen A., Snapir A., Scheinin H., Scheinin M., Meriläinen P., Himanen S.L., Jääskeläinen S.Electroencephalogram spindle activity during dexmedetomidine sedation and physiological sleep. Acta Anaesthesiol. Scand.2008; 52 (2): 289—294.
(check this in PDF content)
27
Sandimenge A.Sedation of ventilated patients and analgesia. Clin. Pulm.Med. 2010; 17 (6): 290—299.
(check this in PDF content)
28
Venn R.M., Karol M.D., Grounds R.M.Pharmacokinetics of dexmedetomidine infusion for sedation of postoperative patients requring intensive care. Br. J. Anaesth.2002; 88 (5): 669—675.
(check this in PDF content)
29
Iirola T., Aantaa R., Laitio R., Kentala E., Lahtinen M., Wighton A., Garratt C., Ahtola=SätiläT., Olkkola K.T.Pharmacokinetics of prolonged infusion of highdose dexmedetomidine in critically ill patients. Crit. Care.2011; 15 (5): R257.
(check this in PDF content)
30
Ruokonen E., Parviainen I., Jakob S.M., Nunes S., Kaukonen M., Shepherd S.T., Sarapohja T., Bratty J.R., Takala J.Dexmedetomidine versus propofol/midazolam for long-term sedation during mechanical ventilation. Intensive Care Med.2009; 35 (2): 282—290.
(check this in PDF content)
31
Talke P., Richardson C.A., Scheinin M., Fisher D.M.Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine. Anesth. Analg.1997; 85 (5): 1136—1142.
(check this in PDF content)
32
Wolf A.M., Fragen R.J., Avram M.J., Fitzgerald P.C., Rahimi=Danesh F. The pharmacokinetics of dexmedetomidine in volunteers with severe renal impairment. Anesth. Analg.2001; 93 (5): 1205—1209.
(check this in PDF content)
33
Iirola T., Ihmsen H., Laitio R., Kentala E., Aantaa R., Kurvinen J.P., Scheinin M., Schwilden H., Schüttler J., Olkkola K.T.Population pharmacokinetics of dexmedetomidine during long-term sedation in intensive care patients. Br. J. Anaesth.2012; 108 (3): 460—468.
(check this in PDF content)
34
Sessler C.N., Gosnell M.S., Grap M.J., Brophy G.M., O’Neal P.V., Keane K.A., Tesoro E.P., Elswick R.K.The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am. J. Respir. Crit. Care Med.2002; 166 (10): 1338—1344.
(check this in PDF content)
35
Pandharipande P.P., Pun B.T., Herr D.L., Maze M., Girard T.D., Miller R.R., Shintani A.K., Thompson J.L., Jackson J.C., Deppen S.A., Stiles R.A., Dittus R.S., Bernard G.R., Ely E.W.Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA.2007; 298 (22): 2644—2653.
(check this in PDF content)
36
Riker R.R., Shehabi Y., Bokesch P.M., Ceraso D., Wisemandle W., Koura F., Whitten P., Margolis B.D., Byrne D.W., Ely E.W., Rocha M.G. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial (SEDCOM). JAMA. 2009; 301 (5): 489—499.
(check this in PDF content)
37
Mason K.P., O’Mahony E., Zurakowski D., Libenson M.H.Effects of dexmedetomidine sedation on the EEG in children. Paediatr. Anaesth. 2009; 19 (12): 1175—1183.
(check this in PDF content)
38
Oda Y., Toriyama S., Tanaka K., Matsuura T., Hamaoka N., Morino M., Asada A.The effect of dexmedetomidine on electrocorticography in patients with temporal lobe epilepsy under sevoflurane anesthesia. Anesth. Analg.2007; 105 (5): 1272—1277.
(check this in PDF content)
39
Talke P., Stapelfeldt C., Garcia P.Dexmedetomidine does not reduce epileptiform discharges in adults with epilepsy. J. Neurosurg. Anesthesiol.2007; 19 (3): 195—199.
(check this in PDF content)
40
Kunisawa T., Kurosawa A., Oikawa M., Mizobuchi M., Hayashi D., Iwasaki H. A high dose of dexmedetomidine using the BIS monitor™ for diagnostic and interventional cardiac catheterization in a toddler with congenital heart disease. J. Anesth.2012; 26 (2): 254—258.
(check this in PDF content)
41
Deyne C., Struys M., Decruyenaere J., Creupelandt J., Hoste E., Colardyn F. Use of continuous bispectral EEG monitoring to assess depth of sedation in ICU patients. Intensive Care Med.1998; 24 (12): 1294—1298.
(check this in PDF content)
42
Fraser G.L., Riker R.R.Bispectral index monitoring in the intensive care unit provides more signal than noise. Pharmacotherapy.2005; 25 (5 Pt 2): 19S—27S.
(check this in PDF content)
43
Riker R.R., Fraser G.L., Simmons L.E., Wilkins M.L.Validating the sedation-agitation scale with the bispectral index and visual analog scale in adult ICU patients after cardiac surgery. Intensive Care Med.2001; 27 (5): 853—858.
(check this in PDF content)
44
Prielipp R.C., Wall M.H., Tobin J.R., Groban L., Cannon M.A., Fahey F.H., Gage H.D., Stump D.A., James R.L., Bennett J., Butterworth J. Dexmedetomidine-induced sedation in volunteers decreases regional and global cerebral blood flow. Anesth. Analg.2002; 95 (4): 1052—1059.
(check this in PDF content)
45
Drummond J.C., Dao A.V., Roth D.M., Cheng C.R., Atwater B.I., Minokadeh A., Pasco L.C., Patel P.M.Effect of dexmedetomidine on cerebral blood flow velocity, cerebral metabolic rate, and carbon dioxide response in normal humans. Anesthesiology.2008; 108 (2): 225—232.
(check this in PDF content)
46
Kadoi Y., Saito S., Kawauchi C., Hinohara H., Kunimoto F.Comparative effects of propofol vs dexmedetomidine on cerebrovascular carbon dioxide reactivity in patients with septic shock. Br. J. Anaesth. 2008; 100 (2): 224—229.
(check this in PDF content)
47
Ogawa Y., Iwasaki K., Aoki K., Kojima W., Kato J., Ogawa S. Dexmedetomidine weakens dynamic cerebral autoregulation as assessed by transfer function analysis and the thighc cuff method. Anesthesiology. 2008; 109 (4): 642—650.
(check this in PDF content)
48
Talke P., Tong C., Lee H.W., Caldwell J., Eisenach J.C., Richardson C.A. Effect of dexmedetomidine on lumbar cerebrospinal fluid pressure in humans. Anesth. Analg.1997; 85 (2): 358—364.
(check this in PDF content)
49
Dahmani S., Paris A., Jannier V., Hein L., Rouelle D., Scholz J., Gressens P., Mantz J.Dexmedetomidine increases hippocampal phosphorylated extracellular signal-regulated protein kinase 1 and 2 content by an alpha 2-adrenoceptor-independent mechanism: evidence for the involvement of imidazoline I1 receptors. Anesthesiology.2008; 108 (3): 457—466.
(check this in PDF content)
50
Шепелюк А.Н., Клыпа Т.В., Никифоров Ю.В.Церебральная оксиметрия для прогнозирования неврологической дисфункции у кардиохирургических пациентов. Общая реаниматология.2011; 7 (1): 48—54.
(check this in PDF content)
51
Шепелюк А.Н., Клыпа Т.В., Никифоров Ю.В.Факторы риска послеоперационных энцефалопатий в кардиохирургии. Общая реанима= тология.2012; 8 (5): 47—55.
(check this in PDF content)
52
Большой психологический словарь. Мещеряков Б.Г., Зинченко В.П. (ред.). М.; 2003.
(check this in PDF content)
53
Головин С. Ю.Словарь практического психолога. М.; 1998.
(check this in PDF content)
54
Карпенко Л.А., Петровский А.В., Ярошевский М.Г.Краткий психологический словарь. Ростов-на-Дону; 1998.
(check this in PDF content)
55
Gaudreau J.D., Gagnon P., Harel F., Tremblay A., Roy M.A.Fast, systematic, and continuous delirium assessment in hospitalized patients: the nursing delirium screening scale. J. Pain Symptom. Manage.2005; 29 (4): 368—375.
(check this in PDF content)
56
Pun B.T., Ely E.W.The importance of diagnosing and managing ICU delirium. Chest.2007; 132 (2): 624—636.
(check this in PDF content)
57
Otter H., Martin J., Bäsell K., von Heymann C., Hein O.V., Böllert P., Jänsch P., Behnisch I., Wernecke K.D., Konertz W., Loening S., Blohmer J.U., Spies C.Validity and reliability of the DDS for severity of delirium in the ICU. Neurocrit. Care.2005; 2 (2): 150—158.
(check this in PDF content)
58
Chevrolet J.C., Jolliet P.Clinical review: agitation and delirium in the critically ill—significance and management. Сrit. Care.2007; 11 (3): 214—218.
(check this in PDF content)
59
Cohen I., Gallagher T.J., Pohlman A.S., Dasta J.F., Abraham E., Papadokos P.J. Management of the agitated intensive care unit patient. Crit. Care Med. 2002; 30 (1): S97-S124.
(check this in PDF content)
60
Ely E.W., Gautam S., Margolin R., Francis J., May L., Speroff T., Truman B., Dittus R., Bernard R., Inouye S.K.The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med.2001; 27 (12): 1892—1900.
(check this in PDF content)
61
Ely E.W., Shintani A., Truman B., Speroff T., Gordon S.M., Harrell F.E.Jr., Inouye S.K., Bernard G.R., Dittus R.S.Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA. 2004; 291 (14): 1753—1762.
(check this in PDF content)
62
Reade M.C., O’Sullivan K., Bates S., Goldsmith D., Ainslie W.R., Bellomo R. Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial. Crit. Care.2009; 13 (3): R75—R84.
(check this in PDF content)
63
Hunter J.C., Fontana D.J., Hedley L.R., Jasper J.R., Lewis R., Link R.E., Secchi R., Sutton J., Eglen R.M.Assessment of the role of alpha2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice. Br. J. Pharmacol. 1997; 122 (7): 1339—1344.
(check this in PDF content)
64
Kalso E.A., Poyhia R., Rosenberg P.H. Spinal antinociception by dexmedetomidine, a highly selective alpha2-adrenergic agonist. Pharmacol. Toxicol. 1991; 68 (2): 140—143.
(check this in PDF content)
65
Sabbe M.B., Penning J.P., Ozaki G.T., Yaksh T.L.Spinal and systemic action of the alpha2 receptor agonist dexmedetomidine in dogs. Antinociception and carbon dioxide response. Anesthesiology.1994; 80 (5): 1057—1072.
(check this in PDF content)
66
Шмидт Р.Ноцицепция и боль. В кн.: Физиология человека. Шмидт Р., Тевс Г. (ред.).гл. 10. СКС; 2002.
(check this in PDF content)
67
Herr D.L., Sum=Ping S.T., England M.ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofolbased sedation regimens. J. Cardiothorac. Vasc. Anesth. 2003; 17 (5): 576—584.
(check this in PDF content)
68
Ebert T.J., Hall E.J., Barney J.A., Uhrich T.D., Colinco M.D.The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology.2000; 93 (2): 382—394.
(check this in PDF content)
69
Hammer G.B., Drover D.R., Cao H., Jackson E., Williams G.D., Ramamoorthy C., Van Hare G.F., Niksch A., Dubin A.M.The effects of dexmedetomidine on cardiac electrophysiology in children. Anesth. Analg.2008; 106 (1): 79—83.
(check this in PDF content)
70
Wijeysundera D.N., Bender J.S., Beattie W.S.Alpha—2 adrenergic agonists for the prevention of cardiac complications among patients undergoing surgery. Cochrane Database Syst. Rev. 2009; 7 (4): CD004126.
(check this in PDF content)
71
Смирнов В.М., Яковлев В.Н.Физиология центральной нервной системы. М.; 2002.
(check this in PDF content)
72
Filosa J.A., Putnam R.W.Multiple targets of chemosensitive signaling in locus coeruleus neurons: role of K+ and Ca2+ channels. Am. J. Physiol. Cell. Physiol.2003; 284 (1): 145—149.
(check this in PDF content)
73
Perez H., Ruiz S.Medullary responses to chemoreceptor activation are inhibited by locus coeruleus and nucleus raphe magnus. Neuroreport. 1995; 6 (10): 1373—1376.
(check this in PDF content)
74
Толкушкина Д.Н.Значение голубого пятна (Locus Coeruleus) в бульбарных механизмах регуляции дыхания. Дисс. ... канд. мед. наук. Самара, 2007.
(check this in PDF content)
75
Andrzejewski M., Mückenhoff K., Scheid P., Ballantyne D.Synchronized rhythms in chemosensitive neurons of the locus coeruleus in the absence of chemical synaptic transmission. Respir. Physiol.2001; 129 (1—2): 123—140.
(check this in PDF content)
76
Hsu Y.W., Cortinez L.I., Robertson K.M., Keifer J.C., Sum=Ping S.T., Moretti E.W., Young C.C., Wright D.R., Macleod D.B., Somma J. Dexmedetomidine pharmacodynamics: part I: crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology.2004; 101 (5): 1066—1076.
(check this in PDF content)
77
Venn R.M., Hell J., Grounds R.M.Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit. Care.2000; 4 (5): 302—308.
(check this in PDF content)
78
Akada S., Takeda S., Yoshida Y., Nakazato K., Mori M., Hongo T., Tanaka K., Sakamoto A.The efficacy of dexmedetomidine in patients with noninvasive ventilation: a preliminary study. Anesth. Analg.2008; 107 (1): 167—170.
(check this in PDF content)
79
Брюк К.Тепловой баланс и регуляция температуры тела. В кн.: Физиология человека. Шмидт Р., Тевс Г. (ред.). гл. 25. СКС; 2002.
(check this in PDF content)
80
Talke P., Tayefeh F., Sessler D.I., Jeffrey R., Noursalehi M., Richardson C. Dexmedetomidine does not alter the sweating threshold, but comparably and linearly decreases the vasoconstriction and shivering thresholds. Anesthesiology.1997; 87 (4): 835—841.
(check this in PDF content)
81
Nseir S., Makris D., Mathieu D., Durocher A., Marquette C.H.Intensive Care Unit-acquired infection as a side effect of sedation. Crit. Care. 2010; 14 (2): R30-R46.
(check this in PDF content)
82
Hofer S., Steppan J., Wagner T., Funke B., Lichtenstern C., Martin E., Graf B.M.,Bierhaus A., Weigand M.A.Central sympatholytics prolong survival in experimental sepsis. Crit. Care.2009; 13 (1): R11.
(check this in PDF content)
83
Kim M.H., Hahn T.H.The effect of clonidine pretreatment on the perioperative proinflammatory cytokines, cortisol, and ACTH responses in patients undergoing total abdominal hysterectomy. Anesth. Analg.2000; 90 (6): 1441—1444.
(check this in PDF content)
84
Taniguchi T., Kurita A., Kobayashi K., Yamamoto K., Inaba H.Dose- and time-related effects of dexmedetomidine on mortality and inflammatory responses to endotoxin-induced shock in rats. J. Anesth.2008; 22 (3): 221—228.
(check this in PDF content)
85
Nishina K., Akamatsu H., Mikawa K., Shiga M., Maekawa N., Obara H., Niwa Y. The effects of clonidine and dexmedetomidine on human neutrophil functions. Anesth. Analg.1999; 88 (2): 452—458.
(check this in PDF content)
86
Maze M., Virtanen R., Daunt D., Banks S.J., Stover E.P., Feldman D. Effects of dexmedetomidine, a novel imidazole sedative-anesthetic agent, on adrenal steroidogenesis: in vivo and in vitro studies. Anesth. Analg.1991; 73 (2): 204—208.
(check this in PDF content)
87
Pettinger W.A., Umemura S., Smyth D.D., Jeffries W.B.Renal alpha 2 adrenoreceptors and the adenylate cyclase-c-AMP system: biochemical and physiological interactions. Am. J. Physiol.1987; 252 (2 Pt 2): F199—F208.
(check this in PDF content)
88
Metz S.A., Halter J.B., Robertson R.P.Induction of defective insulin secretion and impaired glucose tolerance by clonidine. Selective stimulation of alpha-adrenergic pathway. Diabetes.1978; 27 (5): 554—562.
(check this in PDF content)
89
Tan J.A., Ho K.M.Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta-analysis. Intensive Care Med. 2010; 36 (6): 926—939.
(check this in PDF content)
90
Frumento R.J., Logginidou H.G., Wahlander S., Wagener G., Playford H.R., Sladen R.N.Dexmedetomidine infusion is associated with enhanced renal function after thoracic surgery. J. Clin. Anesth. 2006; 18 (6): 422—426.
(check this in PDF content)
91
Iirola T., Vilo S., Aantaa R., Wendelin=Saarenhovi M., Neuvonen P.J., Scheinin M., Olkkola K.T. Dexmedetomidine inhibits gastric emptying and oro-caecal transit in healthy volunteers. Br. J. Anaesth.2011; 106 (4): 522—527.
(check this in PDF content)
92
Leino K., Hynynen M., Jalonen J., Salmenperд M., Scheinin H., Aantaa R. Renal effects of dexmedetomidine during coronary artery bypass surgery: a randomized placebo-controlled study. BMC Anesthesiology. 2011; 11: 9.
(check this in PDF content)
93
Mowafi H.A., Aldossary N., Ismail S.A., Alqahtani J.Effect of dexmedetomidine premedication on the intraocular pressure changes after succinylcholine and intubation. Br. J. Anaesth.2008; 100 (4): 485—489.
(check this in PDF content)
94
Talke P.O., Caldwell J.E., Richardson C.A., Kirkegaard=Nielsen H., Stafford M. The effects of dexmedetomidine on neuromuscular blockade in human volunteers. Anesth. Analg.1999; 88 (3): 633—639.
(check this in PDF content)
95
Jacobi J., Fraser G.L., Coursin D.B., Riker R.R., Fontaine D., Wittbrodt E.T., Chalfin D.B., Masica M.F., Bjerke H.S., Coplin W.M., Crippen D.W., Fuchs B.D., Kelleher R.M., Marik P.E., Nasraway S.A. Jr., Murray M.J., Peruzzi W.T., Lumb P.D.Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit. Care Med.
(check this in PDF content)